RESIDALYA acquired by DOMUSVI

Naxicap Partners entered into exclusive negotiations to acquire a majority stake in Emera. The transaction was highly competitive, involving bidders from both strategic industrial backgrounds and infrastructure funds. To secure the deal, the acquirer formed a partnership with one of its primary subscribers to cover the equity requirement for the "upper mid-cap" valuation. The founding family and the management team significantly reinvested in the operation, with the founder of a major industry peer also joining the round as a strategic minority partner

Colisée Group entered into a definitive agreement to acquire 100% of Armonea to create the fourth-largest elderly care operator in Europe. This transformative acquisition doubled Colisée’s size, resulting in a combined entity with a turnover of approximately €1 billion and a network of 270 facilities across five countries. The merger was strategically designed to capitalize on geographic complementarities, merging Colisée’s strong Mediterranean presence with Armonea’s market leadership in Northern Europe

Humana AB entered into a definitive agreement to acquire 100% of Coronaria Hoiva Oy to significantly expand its operational footprint in the Finnish market. This strategic acquisition was designed to integrate Coronaria Hoiva’s specialized residential care portfolio into Humana’s existing Finnish operations, creating a more diversified and robust platform for social care delivery. The transaction was financed through a combination of existing cash reserves and new credit facilities, and it received formal approval from the Finnish Competition and Consumer Authority in early April

Investindustrial acquired a controlling stake in Lifebrain from the investment vehicle lb EK Management. The deal follows a period of intense growth supported by MCI Capital, during which the group established itself as a leading consolidator in the fragmented Italian laboratory market. The acquisition was structured through a Luxembourg vehicle, European Laboratory Services, and aimed to provide the capital and expertise necessary to professionalize the group and accelerate its aggressive acquisition strategy across Italy

Pan-European private equity firm Hg has successfully completed the divestiture of its majority equity stake in Swedish care provider Frösunda Omsorg AB to Norway-based investment firm The Adolfsen Group. Executed through the holding company Brado—an investment vehicle owned by brothers Kristian and Roger Adolfsen—the transaction concludes a highly successful eight-year holding period for the sponsor. Throughout the targeted sale process, Hg was exclusively advised by investment bank Carnegie, acting as sole financial advisor

ICV Partners has acquired Outpatient Imaging Affiliates (OIA) from its founder, Frank Kyle, and MedCare Investment Funds, a family office. This acquisition represents a platform investment for ICV in the outpatient imaging sector. The firm identified OIA as a well-positioned player due to its partnership-based model with hospital systems, operational expertise, and successful track record of integrating new imaging centers. Given the highly fragmented nature of the US outpatient imaging market, ICV saw this transaction as an opportunity to pursue an active external growth strategy while continuing to drive organic growth

Permira acquired I-MED from EQT Mid Market and its co-investors (GIC and CDPQ) in a competitive auction process. The transaction was structured as a majority buyout, with the existing management team, led by CEO Steven Rubic, rolling over equity and remaining at the helm. Under EQT's previous four-year ownership, I-MED had significantly expanded its footprint through hospital contracts and bolt-on acquisitions. Permira's entry was designed to drive the next phase of growth by further consolidating the fragmented Australian radiology market, investing in advanced imaging technologies, and exploring potential international expansion (including teleradiology)

ICG and founder Yves Journel have entered into exclusive negotiations to acquire the majority stake in DomusVi from PAI Partners. The transaction follows a preemptive bid by ICG that successfully bypassed a formal auction process involving major international investors and sovereign funds. This deal marks a significant change in scale for the group, which was valued at less than €650 million in 2014. The acquisition is structured to maintain the existing high-yield bond financing, as the continued presence of ICG and the founder in the capital prevents the activation of change-of-control repayment clauses

IK Investment Partners, through its IK VIII Fund, reached an agreement with Eurazeo PME and the management team to acquire a majority stake in Colisée. The founding family and management team reinvested alongside IK, ensuring continuity of strategic direction and operational leadership. The investment thesis centres on supporting Colisée's continued growth through selective buy-and-build acquisitions in France and across Europe, as well as the development of innovative services for elderly people

Partners Group and Canadian pension fund PSP entered exclusive negotiations to acquire Cerba from PAI Partners. The consortium beat out CVC and Apax, but most notably rejected a higher offer (>EUR2bn) from industrial player Cinven (owner of Synlab/Labco). Management preferred the financial sponsors to avoid massive cost synergies and restructuring.